EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Weight Loss for Patients With Gout and Concomitant Obesity: A Proof‐of‐Concept Randomized Trial

Robin Christensen iD, Kristian Zobbe iD, Sabrina M Nielsen, Lisa K Stamp iD, Marius Henriksen iD, Anders F Overgaard, Lene Dreyer, Filip K Knop, Jasvinder A Singh iD, Michael Doherty, Pascal Richette, Arne Astrup und 6 weitere

Arthritis & Rheumatology · 2024

DOI: 10.1002/art.42790 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Arthritis & Rheumatology, 2024. Verfasst von Robin Christensen und 17 weiteren Autor:innen. Beteiligte Einrichtung: The Parker Institute, Bispebjerg and Frederiksberg Hospital, University of Copenhagen, Copenhagen, Denmark, and University of Southern Denmark, Odens…. Hauptthemen laut MEDLINE: Gout, Obesity, Proof of Concept Study, Weight Loss. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 18 Literaturangaben. Gefördert von: The Oak Foundation, Oak Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Despite scarce evidence, guidelines recommend weight loss as a management strategy for patients with gout. We investigated the effect of an intensive dietary intervention on body weight and clinical measures of gout severity in individuals with obesity and gout.

Methods

We conducted a 16‐week randomized nonmasked parallel‐group trial in Denmark, randomly assigning (one‐to‐one) individuals with obesity and gout to a low‐energy diet or a control diet. The primary outcome was change in body weight. Key secondary outcomes were changes in serum urate (SU) level and visual analog scale–assessed pain and fatigue.

Results

Between December 1, 2018, and June 1, 2019, 61 participants were included in the intention‐to‐treat population and randomly assigned to the intensive diet group (n = 29) or control diet group (n = 32). Participants had a mean age of 60.3 (SD 9.9) years and mean body mass index of 35.6 (SD 5.0), and 59 (97%) were men. After 16 weeks, there was a significant difference in change in body weight between the diet and control groups (−15.4 vs −7.7 kg; difference −7.7 kg [95% confidence interval −10.7 to −4.7], P < 0.001). Despite results being potentially in favor of a low‐energy diet, we could not confirm differences in SU level changes and fatigue between groups. No differences in pain and gout flares were observed between groups. No serious adverse events or deaths occurred during the trial.

Conclusion

An intensive dietary intervention was safe and effectively lowered body weight in people with obesity and gout, but the weight loss did not directly translate into effects on SU level, fatigue, and pain.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GoutObesityProof of Concept StudyWeight LossAgedFemaleHumansMaleMiddle AgedBody Mass IndexDiet, ReducingFatigueUric Acid

Substanzen

Uric Acid

Autor:innen und Institutionen

  • The Parker Institute, Bispebjerg and Frederiksberg Hospital, University of Copenhagen, Copenhagen, Denmark, and University of Southern Denmark, Odense University Hospital, Odense, Denmark.
  • The Parker Institute, Bispebjerg and Frederiksberg Hospital, University of Copenhagen, Copenhagen, Denmark.
  • Department of Medicine, University of Otago, Christchurch, Christchurch, New Zealand.
  • Aalborg University Hospital, Aalborg, Denmark, and University of Aalborg, Aalborg, Denmark.
  • Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark, Steno Diabetes Center Copenhagen, and Foundation Center for Basic Metabolic Research, Faculty of Health and Medical…
  • Medicine Service, VA Medical Center, Birmingham, School of Medicine, University of Alabama at Birmingham (UAB), and UAB School of Public Health, Birmingham, Alabama.

ORCID-Profile: Robin Christensen, Kristian Zobbe, Lisa K Stamp, Marius Henriksen, Jasvinder A Singh, Karen Ellegaard, Henning Bliddal

Förderung

  • The Oak Foundation
  • Oak Foundation

Zitieren

APA

Christensen, R., Zobbe, K., Nielsen, S. M., Stamp, L. K., Henriksen, M., Overgaard, A. F., Dreyer, L., Knop, F. K., Singh, J. A., Doherty, M., Richette, P., Astrup, A., Ellegaard, K., Bartels, E. M., Boesen, M., Gudbergsen, H., Bliddal, H., & Kristensen, L. E. (2024). Weight Loss for Patients With Gout and Concomitant Obesity: A Proof‐of‐Concept Randomized Trial. Arthritis & Rheumatology. https://doi.org/10.1002/art.42790

Vancouver

Christensen R, Zobbe K, Nielsen SM, Stamp LK, Henriksen M, Overgaard AF, et al. Weight Loss for Patients With Gout and Concomitant Obesity: A Proof‐of‐Concept Randomized Trial. Arthritis & Rheumatology. 2024. doi:10.1002/art.42790

BibTeX
@article{Christensen2024,
  author = {Christensen, Robin and Zobbe, Kristian and Nielsen, Sabrina M and Stamp, Lisa K and Henriksen, Marius and Overgaard, Anders F and Dreyer, Lene and Knop, Filip K and Singh, Jasvinder A and Doherty, Michael and Richette, Pascal and Astrup, Arne and Ellegaard, Karen and Bartels, Else M and Boesen, Mikael and Gudbergsen, Henrik and Bliddal, Henning and Kristensen, Lars Erik},
  title = {Weight Loss for Patients With Gout and Concomitant Obesity: A Proof‐of‐Concept Randomized Trial},
  journal = {Arthritis & Rheumatology},
  year = {2024},
  doi = {10.1002/art.42790}
}
Kostenlos starten →